Evidence map›Paper›PMID 32884791›Full record

ArticleClinical case reports2020

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir

Elizabete Pumpure, Eva Dručka, Dana Kigitoviča, Raimundas Meškauskas, Sergejs Isajevs, Ineta Nemiro, Agnija Rasa, Evija Olmane, Tatjana Zablocka, Pēteris Alberts and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Elizabete PumpureDepartment of Obstetrics and Gynaecology Riga Stradiņš University Riga Latvia.
Eva DručkaDepartment of Internal Diseases Riga Stradiņš University Riga Latvia.
Dana KigitovičaDepartment of Internal Diseases Riga Stradiņš University Riga Latvia.ORCID https://orcid.org/0000-0002-3239-5030
Raimundas MeškauskasNational Center of Pathology Affiliate of Vilnius University Hospital Santaros Klinikos Vilnius Lithuania.
Sergejs IsajevsCentre of Pathology Riga Eastern Clinical University Hospital Riga Latvia.
Ineta NemiroDepartment of Diagnostic Radiology Oncology Centre of Latvia Riga Latvia.
Agnija RasaR&D, Rigvir Riga Latvia.ORCID https://orcid.org/0000-0001-6561-9371
Evija OlmaneDepartment of Radiology Pauls Stradiņš Clinical University Hospital Riga Latvia.
Tatjana ZablockaCentre of Pathology Riga Eastern Clinical University Hospital Riga Latvia.
Pēteris AlbertsR&D, Rigvir Riga Latvia.ORCID https://orcid.org/0000-0001-9585-9288
Simona DoniņaOncology Centre of Latvia Riga East University Hospital Riga Latvia.ORCID https://orcid.org/0000-0002-9264-7383
Riga East University Hospital · LVRiga Stradiņš University · LVLatvian Biomedical Research and Study Centre · LVPauls Stradiņš Clinical University Hospital · LVVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir

Indexed as

ECHO‐7 virusmelanomaoncologyoncolytic virusRigviruterine cervix

Identifiers

PMID32884791
PMCPMC7455402
OpenAlexW3027983335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.